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Mechanisms underlying phenotypic heterogeneity in young onset Alzheimer disease (YOAD) are poorly
understood. We used diffusion tensor imaging and neurite orientation dispersion and density imaging
(NODDI) with tract-based spatial statistics to investigate apolipoprotein (APOE) ε4 modulation of white-
matter damage in 37 patients with YOAD (22, 59% APOE ε4 positive) and 23 age-matched controls.
Correlation between neurite density index (NDI) and neuropsychological performance was assessed in 4
white-matter regions of interest. White-matter disruption was more widespread in ε4þ individuals but
more focal (posterior predominant) in the absence of an ε4 allele. NODDI metrics indicate fractional
anisotropy changes are underpinned by combinations of axonal loss and morphological change. Regional
NDI in parieto-occipital white matter correlated with visual object and spatial perception battery per-
formance (right and left, both p ¼ 0.02), and performance (nonverbal) intelligence (WASI matrices, right,
p ¼ 0.04). NODDI provides tissue-speciﬁc microstructural metrics of white-matter tract damage in YOAD,
including NDI which correlates with focal cognitive deﬁcits, and APOEε4 status is associated with
different patterns of white-matter neurodegeneration.
 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction (Ossenkoppele et al., 2015b). Although the distribution of Ab pla-The biological underpinnings of phenotypic expression in
neurodegenerative disease are poorly understood. Clinical hetero-
geneity is particularly apparent in patients with sporadic young
onset AD (YOAD), deﬁned as symptom onset at less than 65 years
(Rossor et al., 2010). These individuals are more likely to present
with nonamnestic phenotypes, including posterior cortical atrophy
(Tang-Wai et al., 2004), logopenic progressive aphasia (Gorno-
Tempini et al., 2011) and a dysexecutive/behavioural syndromee, UCL Institute of Neurology,
el.: 0203 4483193; fax: 0203
Inc. This is an open access articleques is broadly similar across these atypical phenotypes (Lehmann
et al., 2013), there are marked differences in the focality of tau
tangle pathology (Ossenkoppele et al., 2016) and brain atrophy
(Ossenkoppele et al., 2015a), both of which correlate with symp-
toms (Ossenkoppele et al., 2015a, 2016).
Factors initiating and potentiating this selective vulnerability
and differential expression of pathology across the brain are likely
to be driven, at least in part, by genetic inﬂuences. Apolipoprotein
(APOE) ε4 is the most important genetic risk factor for sporadic AD
(Strittmatter and Roses, 1995). In late onset AD (LOAD), APOE ε4
reduces the age of onset (Corder et al., 1993), is associated with
medial temporal lobe atrophy (Filippini et al., 2009), and tends to
manifest as a ‘typical’ amnestic phenotype (van der Vlies et al.,
2007). However, evidence suggests that patients with atypical
YOAD are less likely to carry an APOE ε4 allele (van der Flier et al.,under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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damage and clinical presentation.
From a mechanistic perspective, a potential unifying explana-
tion for the mismatch between widespread amyloid deposition
and more focal downstream neurodegeneration comes from
prion-like spread of proteinopathies with tropism for speciﬁc
large scale neural networks (Seeley et al., 2009; Warren et al.,
2013). Diffusion tensor imaging (DTI) is a magnetic resonance
(MR) technique for exploring the structural integrity of white-
matter in vivo using water diffusion to distinguish different
microstructural environments. DTI provides voxel-level estimates
of fractional anisotropy (FA), axial diffusivity (AxD), and radial
diffusivity (RD). Neurite orientation dispersion and density im-
aging (NODDI; Zhang et al., 2012) is one of a number of advanced
diffusion MRI techniques designed to probe tissue microstructure
beyond a composite view of each voxel by modeling water diffu-
sion in multiple compartments (Ferizi et al., 2014), that is, diffu-
sion that is restricted in axons and dendrites, hindered in
extraneurite space and isotropic in cerebrospinal ﬂuid. NODDI
derives a neurite density index (NDI), orientation dispersion index
(ODI), and the fraction of free water (Fiso; Fig. 1). This model allows
axonal loss in white matter (NDI) to be distinguished from altered
patterns of axonal organization (ODI) on a voxel-by-voxel basis,
thereby disentangling 2 key factors contributing to changes in FA.
Similar to DTI, NODDI can be implemented with standard
diffusion-weighted imaging sequences making it accessible for
routine clinical studies. Its utility has beenwidely demonstrated in
a broad range of applications, including Parkinson’s disease
(Kamagata et al., 2016), epilepsy (Winston et al., 2014), normal
aging (Billiet et al., 2015), brain development (Kunz et al., 2014),
and neurogenetic disorders (Timmers et al., 2015).
In this study, we apply DTI and NODDI to a population of patients
with YOAD and healthy controls to investigate the nature of
microstructural damage underpinning changes in FA and test the
hypotheses that (1) APOE ε4 status modulates regional signatures of
white-matter network breakdown and (2) reduction inwhite-matter
NDI, reﬂectingneurite loss, inﬂuences the clinicalphenotypeofYOAD.
2. Methods and materials
2.1. Study participants
Forty-ﬁve patients meeting consensus criteria for probable AD
(McKhann et al., 2011) with symptom onset <65 years wereFig. 1. Diffusion tensor imaging (DTI) and neurite orientation dispersion and density imag
tensor, hence gives a composite view of tissue microstructure. NODDI models each voxel as
and cerebrospinal ﬂuid (isotropic diffusion). Dendrites and axons, collectively known as ‘neu
orientation dispersion index (ODI), speciﬁcally in the intraneurite compartment, without precruited prospectively from 2013 to 2015 from a specialist
Cognitive Disorders clinic. None had a known mutation or family
history suggestive of autosomal dominant inheritance. The pre-
senting cognitive symptom was recorded for all patients, and
patients were classiﬁed as having a typical (McKhann et al., 2011)
or atypical (posterior cortical atrophy [Tang-Wai et al., 2004])
AD phenotype according to published criteria. Twenty-four
healthy controls matched for mean age and gender were
recruited. All participants underwent MRI scanning, testing on the
MinieMental State Examination (MMSE; Folstein et al., 1975),
assessment on the Hachinski Ischaemic Score (Moroney et al.,
1997), and an extensive neuropsychology battery designed to
capture phenotypic diversity in YOAD including: assessment of
general intellect (vocabulary and matrices subtests of the
Wechsler Abbreviated Scale of Intelligence, WASI [Wechsler,
1999]), episodic memory for faces and words (Recognition Mem-
ory Test, RMT [Warrington, 1984]), numeracy, and literacy (Graded
Difﬁculty Arithmetic, GDA [Jackson and Warrington, 1986];
Graded Difﬁculty Spelling Test, GDST [Baxter and Warrington,
1994]), visuospatial, and visuoperceptual performance (Visual
Object and Spatial Perception battery, VOSP [Warrington and
James, 1991]), speed of processing and executive function
(DKEFS, Delis-Kaplan Executive Function Systemedesign ﬂuency
test, DKEFS (Delis et al., 2001); Digit Symbol Modalities Test, DSMT
(Smith, 1986); verbal ﬂuency). Ethical approval was obtained from
the National Hospital for Neurology and Neurosurgery Research
Ethics Committee and written informed consent obtained from all
the participants.2.2. APOE genotyping
Patient participants gave separate speciﬁc consent to donate
blood for genetic analyses. DNA was extracted and APOE genotype
was determined by PCR with 30-minor groove binding probes.2.3. MRI acquisition
MRI was performed on a Siemens Magnetom Trio (Siemens,
Erlangen, Germany) 3T MRI scanner using a 32-channel phased
array head coil. Two identical diffusion-weighted imaging ac-
quisitions were performed using a single-shot, spin-echo echo
planar imaging sequence (64 diffusion-weighted directions,
b ¼ 1000 s/mm2; 9 b ¼ 0 s/mm2 images (referred to as ‘b0’ images);ing (NODDI) models for diffusion-weighted MRI. DTI models each voxel using a single
3 compartments: intraneurite (restricted diffusion), extraneurite (hindered diffusion),
rites’, are projections of neurons. NODDI can estimate neurite density index (NDI) and
artial volume effects from free water.
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acquisition time for both sequences ¼ 16:29 minutes). A 3-shell
diffusion sequence optimized for NODDI was acquired (64, 32,
and 8 diffusion-weighted directions at b ¼ 2000, 700, and
300 s/mm2; 14 b ¼ 0 images; 55 slices; voxel size 2.5  2.5 
2.5 mm3; TR/TE ¼ 7000/92 ms; total acquisition time ¼ 16:13
minutes). Both single-shell (DTI) and multishell (NODDI) diffusion-
weighted sequences utilize twice-refocused spin echo to minimize
distortion effects from eddy-currents. All scans were assessed for
quality control purposes, based on coverage andmovement artifact.2.4. DTI and NODDI image processing
Sixty participants (37 YOAD, 23 controls) had both DTI
and NODDI data that passed quality control criteria and were
included for analysis. Images were conﬁrmed to have minimal
eddy-current distortion and were corrected for motion by rigidly
registering each diffusion-weighted image to the ﬁrst b0 image
using FLIRT (Jenkinson and Smith, 2001; Jenkinson et al., 2002).
Diffusion tensor volumes were spatially normalized with DTI-TK
(http://dti-tk.sourceforge.net) which bootstraps a population-
speciﬁc tensor template from the input tensor volumes and aligns
them to the template in an iterative fashion (Zhang et al., 2007)
with a tensor-based registration algorithm (Zhang et al., 2006). This
framework has been shown to improve white-matter alignment
compared with conventional FA-based registration (Wang et al.,
2011). DTI metrics (FA, AxD, RD) were estimated using FSL
(Jenkinson et al., 2012). NODDI metrics (NDI, ODI, Fiso) were esti-
mated using the NODDI Matlab toolbox (http://www.nitrc.org/
projects/noddi_toolbox).Table 1






Sex, M:F, n 10:13 - 18:19
Age (y) 60.7 6.0 62.3
Handedness, L:R, n 3:20 - 1:36
Years of education 16.7 3.1 14.9
MMSE (/30) 29.3 1.0 21.3
Age at onset (y) - - 56.8
Disease duration (y) - - 5.4
Neuropsychology
General intellect: verbal IQ (WASI vocabulary),
z score
- - 1.15
General intellect: performance IQ
(WASI matrices), z score
- - 5.80
Episodic memory for faces (RMT), z score - - 1.90
Episodic memory for words (RMT), z score - - 4.35
Literacy and numeracy (GDST, GDA), z score - - 2.04
Visuoperceptual and visuospatial (VOSP),
z score
- - 6.81
Speed of processing and executive function






Neuropsychology scores shown are mean z scores for each cognitive domain (a z score
Probability values for neuropsychology scores show signiﬁcance value comparing APOE
Key: APOE, apolipoprotein E; DKEFS, Delis-Kaplan Executive Function System (design ﬂ
Arithmetic; GDST, Graded Difﬁculty Spelling Test; IQ, intelligence quotient; M, male; MM
positive; RMT, Recognition Memory Test; SD, standard deviation; VOSP, Visual Object and
young onset Alzheimer’s disease.
a Two-sided Fisher’s exact.
b Two-tailed t-test.
c Wilcoxon rank sum.2.5. Statistical analyses
Patient neuropsychology raw scores (x) were converted to z
scores using the formula z ¼ (x  m)/s (sdcontrol population
standard deviation, mdcontrol population mean). Mean z scores
were calculated for each neuropsychological test within participant
groups, and across neuropsychological tests (where applicable) to
generate a composite score for each cognitive domain (Table 1).
Statistical tests comparing clinical characteristics and neuropsy-
chology scores were performed in Stata version 12.
The Tract-Based Spatial Statistics (Smith et al., 2006) pipeline
from FSL (Smith et al., 2004), optimized (Bach et al., 2014) by
incorporating a population-speciﬁc template (Keihaninejad et al.,
2012) with tensor-based registration (Keihaninejad et al., 2013;
Zhang et al., 2006) as described in 2.4, was used to detect whole-
brain white-matter differences between YOAD groups as deﬁned
by APOE ε4 status relative to controls, including age and gender as
covariates (5000 permutations, corrected for multiple comparisons
with Threshold-Free Cluster Enhancement [Winkler et al., 2014], p
< 0.05).
To assess the relationship between microstructural tissue
changes and clinical phenotype in YOAD patients, correlations be-
tween NDI, ODI, and Fiso with neuropsychological performance
(z scores by cognitive domain) were assessed in 4manually-deﬁned
regions of interest corresponding to left and right posterior quad-
rants (parieto-occipital lobe projections) and left and right anterior
quadrants (fronto-temporal lobe projections) of the mean white-
matter skeleton. These ROIs were delineated by dividing the
white-matter skeleton into 4 areas at coordinates (x ¼ 112, y ¼ 88)
in standard template space. Mean NODDI metrics (NDI, ODI, and





SD Mean SD Mean SD
- 0.8a 7:8 - 11:11 - 1.0a
4.9 0.3b 60.2 3.8 63.6 5.2 0.03b
- 0.2a 0:15 - 1:21 - 1.0a
2.8 0.03a 15.5 2.3 14.5 3.0 0.3a
4.5 <0.0001c 19.9 4.4 22.3 4.4 0.1c
4.4 n/a 55.4 4.3 57.8 4.4 0.1b
3.2 n/a 4.8 3.0 5.9 3.3 0.3b
1.9 - 1.56 2.3 0.88 1.6 0.4c
2.4 - 6.24 2.3 5.43 2.39 0.4c
1.8 - 1.65 1.3 2.08 2.1 0.6c
2.6 - 4.38 2.7 4.33 2.5 0.8c
1.3 - 2.54 1.0 1.70 1.4 0.04b
6.5 - 8.34 5.7 5.76 7.0 0.09c
0.8 - 2.6 0.7 1.97 0.7 0.01c
n n
n/a 8/7/0/0 16/6/0/0 0.3a
<1.96 indicates statistical difference from controls at p < 0.05, indicated in bold).
ε4 and APOE ε4þ patient groups.
uency test); DSMT, Digit Symbol Modalities Test; F, female; GDA, Graded Difﬁculty
SE, MinieMental State Examination; n, number; neg, negative; p, probability; pos,
Spatial Perception battery; WASI, Wechsler Abbreviated Scale of Intelligence; YOAD,
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as covariates and correlations with a p < 0.05 were reported.3. Results
3.1. Demographics, clinical and genetic characteristics
Demographic and clinical data for participant groups are sum-
marized in Table 1. Mean age and gender did not differ signiﬁcantly
between patients and controls (age, p¼ 0.3; gender, p¼ 0.8), and no
individual scored >4 on the Hachinski Ischaemic Score. APOE ε4
status was available for the 37 YOAD patients, of whom 22 (59%)
were APOE ε4 positive (18 heterozygotes, 4 homozygotes). Patients
who had an APOE ε4 allele (ε4þ) were signiﬁcantly older than those
who did not (ε4 negative patients, ε4) at enrollment to the study
(p ¼ 0.03). There were no signiﬁcant differences between ε4þ and
ε4 patients for age at clinical symptom onset, clinical disease
duration at enrollment to the study, or MMSE. The majority of ε4þ
patients presented with a ‘typical AD’ amnestic phenotype (16/22,
73%; 3/4, 75% of the ε4þ homozygotes), whereas the ε4 patients
contained approximately equal numbers of individuals with an
amnestic (8/15, 53%) and atypical visual-led posterior cortical at-
rophy presentations (7/15, 47%); or alternatively expressed 67% ofFig. 2. DTI and NODDI metrics in patients with (A) ε4 YOAD (n15) and (B) ε4þ YOAD (n
metrics that are decreased in patients and blue for those increased in patients. Results are ov
in green) in neurologic convention (the left side appears on the left). Abbreviations: AxD,
neurite density index; ODI, orientation dispersion index; R, right; RD, radial diffusivity; YOA
ﬁgure legend, the reader is referred to the Web version of this article.)the amnestic patients carried one or more ε4 alleles, whereas only
46% of the nonamnestic patients were ε4þve.3.2. Neuropsychological proﬁles
Neuropsychological analyses showed that as expected, patients
with YOAD had multidomain cognitive impairment, performing
signiﬁcantly less well than controls onmeasures of performance IQ;
recognitionmemory for words; literacy and numeracy; visuospatial
and visuoperceptual performance; speed of information processing
and executive function (Table 1). ε4 patients were more impaired
on tests of literacy and numeracy (p ¼ 0.04) and speed of infor-
mation processing and executive function (p ¼ 0.01) than ε4þ
positive patients, despite there being no signiﬁcant difference in the
clinical disease durations between the patient groups.3.3. White-matter structural differences by APOE ε4 genotype
DTI and NODDI metrics are shown for ε4 and ε4þ patients
relative to controls in Fig. 2. Both patient groups had decreased FA
in white-matter tracts projecting from the parieto-occipital lobes
(inferior longitudinal fasciculus, inferior fronto-occipital fasciculus,
superior longitudinal fasciculus, genu of corpus callosum, posterior¼ 22) relative to controls (n ¼ 23). Voxel-wise group differences are shown in red for
erlaid on axial and sagittal sections of the group-speciﬁc white-matter skeleton (shown
axial diffusivity; FA, fractional anisotropy; Fiso, fraction of isotropic water; L, left; NDI,
D, young onset Alzheimer’s disease. (For interpretation of the references to color in this
C.F. Slattery et al. / Neurobiology of Aging 57 (2017) 8e1712thalamic radiation), with ε4 patients also having decreased FA in
the splenium of the corpus callosum and anterior corona radiata.
AxD and RD were increased in both patient groups relative to
controls in the genu, body and splenium of the corpus callosum,
and parieto-occipital white-matter projections (those listed above
and the internal capsules). ε4þ patients additionally had increased
RD in the white-matter projections from the frontal lobes. There
were no areas where patients had increased FA or decreased
diffusivity relative to controls, and no signiﬁcant differences in any
DTI metric when APOE ε4þ and ε4 groups were compared
directly.
The tissue speciﬁcity afforded by NODDI revealed a landscape of
microstructural damage in YOAD underpinning these changes in
DTI metrics; for example, identifying areas of FA reduction specif-
ically due to decreased NDI rather than changes in ODI (Fig. 3A).
NODDImetrics could also be more sensitive to change; for example,
identifying regions where NDI and ODI reduction occurred in par-
allel, hence resulting in no overall FA change (Fig. 3B).
NDI was reduced in the parieto-occipital white-matter pro-
jections (same as listed above) of both ε4 and ε4þ patient groups
relative to controls but was strikingly more widespread in ε4þ
patients, additionally affecting the body and genu of the corpus
callosum, and extending further into the frontal and temporal lobe
white-matter projections. ε4 and ε4þ patient groups had a com-
mon signature of decreased ODI in the posterior parts of the corpus
callosum and internal capsule. ε4 patients also had increased Fiso
in the corpus callosum, whereas there were no signiﬁcant differ-
ences in Fiso in ε4þ patients relative to controls. There were no
signiﬁcant differences in any NODDI metric when directly
comparing ε4 and ε4þ patient groups at the prescribed statistical
threshold; however plotting the NDI t-statistic maps (uncorrected;
Fig. 4) revealed that ε4 patients had the greatest NDI reduction
relative to ε4þ in the right parietal lobe white-matter projections;
and ε4þ patients had greatest reduction in NDI relative to ε4 in
the left temporal lobe projections.
3.4. Region of interest NDI correlations with cognitive function
Raw values for NODDI metrics in each of the 4 regions of interest
are shown in Table 2. There were signiﬁcant differences between
patients and control NDI metrics in each of the 4 quadrants. In
patients, there were signiﬁcant positive correlations between a
visually-demanding measure of performance IQ (WASI matrices)
and regional NDI in white-matter projections from the right
parieto-occipital lobe (Fig. 5A) and between visuospatial and
visuoperceptual tasks and NDI inwhite-matter projections from the
parieto-occipital lobes bilaterally (Fig. 5B and C). There were no
signiﬁcant positive correlations between NDI and performance on
other cognitive domains, and no signiﬁcant negative correlations
between regional NDI and any cognitive score. Regional ODImetrics
did not correlate with any cognitive score. Fiso in the left posterior
quadrant correlated with patient episodic memory for words
(r ¼ 0.4, p ¼ 0.01).
4. Discussion
In this study, we used DTI and NODDI to explore signatures of
white-matter structural brain damage and their biological un-
derpinnings in patients with YOAD on the basis of APOE ε4 geno-
type. DTI metrics showed regions of altered white-matter
microarchitecture in both ε4þ and ε4 patients relative to controls.
NODDI, a multishell diffusion technique implemented on standard
3T clinical MR scanners, provided further insights into the com-
monalities and differences in white-matter change associated with
ε4 genotype; namely more widespread NDI reduction in ε4þindividuals and more focal posterior reductions in patients without
an ε4 allele. Finally, reduction in regional NDIdspeciﬁcally
modeling axonal loss in white matterdcorrelated with patterns of
focal cognitive impairment, suggesting that NODDImetrics not only
provide insights into regional white-matter vulnerability but also
have relevant clinical correlates.
Despite being the most important risk factor for AD, the effects
of APOE ε4 on clinical phenotype white-matter damage are
incompletely understood. Our observation that ε4 negative patients
are impaired more than ε4 positive patients on neuropsychological
tests of literacy and numeracy, and speed of information processing
and executive function, is consistent with ﬁndings from several
previous studies whereby 34 patients were shown to be more
impaired in nonmemory cognitive domains (van der Flier et al.,
2011). The relatively few previous DTI studies in YOAD have
shown decreased white-matter FA and increased diffusivity but
have focused on describing regional variation between phenotypes
(Caso et al., 2015; Cerami et al., 2015; Madhavan et al., 2016) or in
YOAD relative to LOAD (Canu et al., 2013) rather than investigating
potential differential effects of APOE ε4. Studies in LOAD have
shown contradictory ﬁndings: APOE ε4 allele status was associated
with an increase in parahippocampal white-matter mean diffu-
sivity (Wang et al., 2012), yet Kljajevic et al. found ε4 status affected
mean diffusivity in controls, but not in participants with clinically-
manifest AD (Kljajevic et al., 2014). Our observation that axial and
radial diffusivity changes are more prominent than FA in both the
presence and absence of an ε4 allele is consistent with previous
observations that these directional diffusivity metrics can be amore
sensitive marker of structural change than FA (Acosta-Cabronero
et al., 2010). The areas of increased RD and AxD, and FA reduction
in bilateral parietal lobes, genu of the corpus callosum, frontal
white-matter lobe projections, we report are broadly in keeping
with changes in DTI metrics reported in YOAD patients (ε4 status
unspeciﬁed) previously (Canu et al., 2013), and we additionally
show that ε4 status appears to have a modulating effect: less
anterior FA reduction in the presence of an ε4 allele. Our NODDI
results allow more speciﬁc inferences about the nature of the un-
derlying microstructural damage. Thus, as illustrated in Fig. 3.
NODDI metrics can explain different mechanisms underlying
changes in FA; or indeed detect the effects of concomitant patho-
logical processes that would individually affect FA in opposing ways
and hence cancel one another out, resulting in no observable FA
change.
White-matter NDI reduction was more extensive anteriorly in
ε4þ than ε4 YOAD patients (Fig. 2). Although differences did not
survive the statistical threshold for multiple comparisons when
comparing the patient groups directly, t-statistic maps (uncorrec-
ted) reveal subtle differences in regional NDI values between the
ε4 and ε4þ groups (Fig. 4). The former had more NDI loss in right
parietal lobe white-matter connections, in keeping with a trend for
worse performance on visual tasks. Conversely, the ε4þ group had
more NDI reduction in left temporal lobe connections. The simi-
larities and differences are consistent with there being a “generic”
signature of network breakdown in AD, with relatively subtle ε4
modulation of network dysfunction, perhaps inﬂuencing pheno-
type through differential propagation of pathology.
Histological evidence supports a relationship between MRI es-
timates of axonal density reduction and actual axon loss. Ex vivo
studies in animals have demonstrated that diffusion MRI estimates
of axon density, using a related diffusion model, show a high degree
of correlation with optical staining intensity of myelin and stereo-
logical estimates of axonal volume fraction in white matter
(Jespersen et al., 2010). If reduced NODDI, NDI truly reﬂects axon
loss in YOAD, then it follows that even partial disconnection of
brain regions should lead to functional consequences that manifest
Fig. 3. Added sensitivity and speciﬁcity of NODDI over DTI. (A) Left posterior white microstructural changes in ε4þ (n ¼ 22) relative to controls (n ¼ 23). Patients with ε4þ YOAD have
lower FA and increased RD. NODDI metrics for this region suggest that the underlying microstructural change is decreased neurite density, rather than alteration in neurite orientation,
illustrating the additional speciﬁcity of NODDI. (B) Right frontal white microstructural changes in ε4þ (n ¼ 22) relative to controls (n ¼ 23). There is no signiﬁcant change in FA. However,
AD increases suggesting underlying microstructural damage, which is corroborated by NODDI metrics revealing reduction in both NDI and ODI (which would tend to affect FA in opposite
directions and hence manifest as no overall change in FA). Here, NODDImetrics are more sensitive than FA by avoiding canceling effects. Abbreviations: AxD, axial diffusivity; FA, fractional
anisotropy; L, left; NDI, neurite density index; NODDI, neurite orientation dispersion and density imaging; ODI, orientation dispersion index, R, right; RD, radial diffusivity.
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Fig. 4. Coronal (left), sagittal (middle), and axial (right) neurite density index t-statistic maps showing areas where APOE ε4 patients have reduced NDI relative to ε4þ patients
(warm colors) and where ε4þ patients have reduced NDI relative to ε4 patients (cool colors). (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the Web version of this article.)
Table 2
NODDI metrics in each region of interest
WM ROIs YOAD Controls pa
NDI (mean  SD)
Left anterior quadrant 0.554  0.022 0.538  0.031 0.043
Left posterior quadrant 0.559  0.029 0.518  0.031 <0.00002
Right anterior quadrant 0.555  0.022 0.539  0.036 0.067
Right posterior quadrant 0.552  0.029 0.511  0.052 0.001
ODI (mean  SD)
Left anterior quadrant 0.214  0.015 0.214  0.007 0.95
Left posterior quadrant 0.202  0.023 0.201  0.007 0.76
Right anterior quadrant 0.213  0.014 0.211  0.008 0.54
Right posterior quadrant 0.195  0.013 0.194  0.008 0.68
Fiso (mean  SD)
Left anterior quadrant 0.105  0.017 0.108  0.016 0.67
Left posterior quadrant 0.107  0.024 0.111  0.017 0.58
Right anterior quadrant 0.099  0.017 0.106  0.018 0.22
Right posterior quadrant 0.101  0.023 0.111  0.034 0.26
Key: Fiso, fraction of free water; NDI, neurite density index; NODDI, neurite orien-
tation dispersion and density imaging; ODI, orientation dispersion index; p, prob-
ability; ROI, region of interest; SD, standard deviation; WM, white matter; YOAD,
young onset Alzheimer’s disease.
a Two-tailed t-test.
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compartment-speciﬁc microstructural changes, previous studies
have shown correlation with global measures of cognition. In pa-
tients with LOAD, fractional anisotropy in the corpus callosum has
been shown to correlate with performance on the MMSE (Canu
et al., 2013), and more speciﬁcally, radial diffusivity and fractional
anisotropy in the splenium correlate with dementia severity on the
ACE-R (Acosta-Cabronero et al., 2012). In YOAD, global cognitive
performance on the Clinical Dementia Rating Sum of Boxes has
been found to correlate with mean diffusivity in several brain re-
gions including the corpus callosum, posterior cingulate, frontal
and parietal parts of the superior longitudinal fasciculus bilaterally,
and left temporal regions (Canu et al., 2013). However, no correla-
tion has been demonstrated between diffusion MRI metrics and
performance on focal cognitive test scores sensitive to regional
brain dysfunction. We found that NDI in white-matter projections
from both left and right parieto-occipital lobes correlated with vi-
suospatial and visuoperceptive cognitive performance, a sensitive
marker of nondominant parietal cortex function; bilateral correla-
tions are likely to reﬂect that the parietal lobes are structurally
closely interconnected. Right parieto-occipital white-matter NDI
also correlated with a measure of performance (nonverbal) intel-
ligence, reﬂecting right hemisphere dysfunction. These correlations
suggest that regional reductions in NDI can provide in vivo mea-
sures of cell loss and network breakdown, which in turn shape
clinical phenotype. The lack of correlation of NDI with other neu-
ropsychological scores may reﬂect these cognitive functions being
underpinned by a more distributed white-matter network or relate
to the dispersion of results on psychology testingdthe tests that
showed correlation were those with the largest range of patient
performance. The ﬁnding of a positive correlation between Fiso (i.e.,
increased water content) in the left posterior quadrant and better
episodic memory for words in the patients was unexpected. Unlike
neurite density which would be expected to closely relate to brain
function and showed differences betweenpatients and controls, the
signiﬁcance of free waterdwhich did not show differences be-
tween patients and controls, is far from clear, and we suspect may
be a false-positive ﬁnding.
Orientation dispersion relates to axonal organization (Jespersen
et al., 2012) and white-matter ODI has been reported to increase in
normal aging (Billiet et al., 2015). We found ODI to be reduced (i.e.,
the tracts were more coherent) in the corpus callosum and internal
capsule of individuals in both ε4 and ε4þ YOAD patients relative
to controls, notably even in some regions unaffected by signiﬁcant
NDI change. The anatomical dissociation may suggest alterations in
NDI and ODI reﬂect different pathophysiological phenomena inneurodegeneration. One possible histological explanation is that
reduced orientation dispersion reﬂects loss of secondary crossing
ﬁbers to leave more aligned neurons in the primary tracts, perhaps
mediated by selective axonal degeneration. However, the lack of
correlation between regional ODI with neuropsychological scores
suggests that neurite density may be more critical for cognitive
function.
This study has a number of limitations. As with all biophysical
models, and speciﬁcally multi-compartment diffusion models,
NODDI requires a number of assumptions: modeling axon orien-
tation does not account for crossing ﬁbers, the value of intrinsic
diffusivity is ﬁxed over the whole brain, and intraneurite diffusion
is modeled as being completely restricted within a collection of
impermeable sticks. It is conceivable that this does not fully char-
acterize all pathological processes involved in neurodegenerative
diseases (e.g., AD) such as possible regional variation in intrinsic
diffusivity, alterations in neurite membrane permeability or dam-
age to intraneurite architecture. Jesperson et al. have used a related
multi-compartment diffusion model (Jespersen et al., 2007) to
examine the relationship between neurite density and orientation
dispersion with histological measures in animal brains (Jespersen
et al., 2010). There is currently limited histopathological evidence
to speciﬁcally validate NODDI model metrics in the human brain;
however an ex vivo study of human spinal cord in multiple sclerosis
Fig. 5. Signiﬁcant correlations between regional neurite density index and neuropsychological measures in white-matter projections from the right (A and B) and left (C) parieto-
occipital cortices of patients with YOAD (n ¼ 37). Regions of interest (red) are shown on the group mean white-matter skeleton (green) to the left of each graph. Abbreviations: IQ,
intelligence quotient; L, left; R, right; VOSP, visual object and spatial perception battery; WASI, Wechsler Abbreviated Scale of Intelligence. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the Web version of this article.)
C.F. Slattery et al. / Neurobiology of Aging 57 (2017) 8e17 15showed NODDI replicated the trends of histological indices and
could detect speciﬁc features of tissue pathology (Grussu et al.,
2015).
We also do not account for the potential presence of white-
matter hyperintensities (WMHs) which have been shown to
result in lower FA and higher MD relative to normal appearing
white matter (Maniega et al., 2015). In AD, WMHmay be related to
coexistent vascular burden, or be part of AD pathogenesis. One of
the advantages of studying patients with YOAD is that they are less
likely to have signiﬁcant coexistent vascular disease than in-
dividuals with late onset disease, and all participants in this study
scored 4 or less on the Hachinski Ischaemic score indicating that on
clinical grounds there was not a signiﬁcant vascular component to
their syndrome. There may be more amyloid angiopathy observedin patients with ε4 positive disease than those who do not carry an
ε4 allele (Shinohara et al., 2016) which could both explain some of
the differences we observed. It is unknown how the presence of
different causes of WMH affects NODDI metricsdand indeed future
studies with post-mortem veriﬁcation are needed to see if NODDI
may be a useful imaging technique to understand the microstruc-
tural changes underpinning these white-matter alterations. If
quantiﬁable, WMH lesions loads could be included as a covariate in
the modeling.
The participant groups we report are relatively small, yet
indicative of the relative rarity of YOAD and may explain why direct
comparisons of ε4þ and ε4 groups were not sufﬁciently powered
to reach statistical signiﬁcance. Although all patient participants
met consensus criteria for probable AD, there was no pathological
C.F. Slattery et al. / Neurobiology of Aging 57 (2017) 8e1716evidence available to conﬁrm underlying AD pathology. Finally,
Alzheimer disease is a complex genetic disease and any modulation
of network breakdown due to APOE ε4 here observed likely occurs
in the context of attenuation by a host of other genetic and envi-
ronmental factors.
NODDI metrics in the healthy aging brain show good short in-
terval reproducibility (Chang et al., 2015) but longitudinal studies,
ideally with post-mortem histological evaluation, are required to
establish if NODDI metrics are robust, reproducible, and capable of
tracking Alzheimer’s disease progression, characteristics that may
give the technique utility in clinical trials. Given the interest in
testing potential therapeutic agents at earlier stages of disease, it
will be important to assess ifdas predicteddNODDI metrics can
detect white-matter microstructural changes in people with very
mild or pre-symptomatic stages of disease. NODDI could also be
applied to studying cortical diffusion in gray matter where micro-
structural changes may be more sensitive and speciﬁc than the
macrostructural damage observed as cortical atrophy, and we may
expect to see closer correlation between regional NODDI metrics
and performance on neuropsychological tests. Finally, in a wider
context beyond AD, NODDI may further inform our understanding
of network changes in normal aging and other neurodegenerative
diseases.
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